Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares RepurchasedShort-Term Debt repayments
Ratios

Pediatrix Medical (MD) Short-Term Debt repayments (2016 - 2024)

Pediatrix Medical (MD) has disclosed Short-Term Debt repayments for 15 consecutive years, with $145.0 million as the latest value for Q2 2024.

  • On a quarterly basis, Short-Term Debt repayments fell 47.84% to $145.0 million in Q2 2024 year-over-year; TTM through Mar 2025 was $145.0 million, a 68.38% decrease, with the full-year FY2024 number at $235.5 million, down 50.32% from a year prior.
  • Short-Term Debt repayments was $145.0 million for Q2 2024 at Pediatrix Medical, up from $90.5 million in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $381.0 million in Q2 2020 to a low of $90.0 million in Q3 2023.
  • A 4-year average of $187.5 million and a median of $146.5 million in 2020 define the central range for Short-Term Debt repayments.
  • Peak YoY movement for Short-Term Debt repayments: plummeted 83.08% in 2020, then rose 25.23% in 2023.
  • Pediatrix Medical's Short-Term Debt repayments stood at $381.0 million in 2020, then plummeted by 35.3% to $246.5 million in 2022, then tumbled by 63.49% to $90.0 million in 2023, then surged by 61.11% to $145.0 million in 2024.
  • Per Business Quant, the three most recent readings for MD's Short-Term Debt repayments are $145.0 million (Q2 2024), $90.5 million (Q1 2024), and $90.0 million (Q3 2023).